Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0345904 (
liver cancer
)
15,188
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Diethylnitrosamine
(
DEN
) was applied orally to a total of 250 female Wistar rats in a single dose (d) of 3 mg/kg body weight 5 times a week for a duration of 20 weeks. After approximately 150 days exploratory laparotomy was performed to all animals. By inspection of the liver they were divided into 4 stages of disease according to the extent of cancer formation. The reaction of rats with
DEN
induced liver tumors was tested using a 4-drug combination chemotherapy with different equitoxic doses of Adriamycin (Adm), Methotrexate (Mtx), 5-Fluorouracil (5-FU) and Cyclophosphamide (CP). No benefit of drug treatment could be noted. In drug treated animals no decrease in the development of the liver tumors, in the frequency of metastases nor in the frequency of tumors of other origin could be demonstrated. The parallels of chemotherapy in chemically induced
liver cancer
to clinical experience are discussed.
...
PMID:Chemotherapy studies in autochthonous rat tumors: hepatomas. 20 2
We have developed a medium-term bioassay system of 8 weeks duration utilizing male Fischer 344 (F344) rats for detection of liver carcinogens and modifiers of hepatocarcinogenesis. The system consists of a single intraperitoneal injection of diethylnitrosamine (
DEN
, 200 mg/kg), 6-weeks-administration of test chemical beginning 2 weeks after the
DEN
injection, and 2/3 partial hepatectomy (PH) performed at week 3. Carcinogenic potency of test chemicals is predicted based on the results of quantitative analyses of immunohistochemically-demonstrated glutathione S-transferase placental form (GST-P) positive liver cell foci. At present, a total of 140 chemicals have been tested using this system, and the findings show a good correlation with reported carcinogenic activities in long-term tests. Furthermore, the reliability of the system has been extensively examined: the results from the medium-term bioassay were compared with those from long-term experiments using the same doses of selected chemicals; the data from presently-used 2-dimensional analysis were compared with calculated values utilizing mathematical formulae for three-dimensional analysis: conformity of phenotypic expression of enzymes in preneoplastic lesions was examined in relation to their growth activity. In conclusion, although the results with non-hepatocarcinogens were less than satisfactory, the present experimental protocol, which requires far fewer animals and shorter duration than a long-term carcinogenicity test, appears of advantage for rapid screening of the large number of environmental chemicals which may possess hazard potential for induction of
liver cancer
in man.
...
PMID:Medium-term bioassay system for detection of carcinogens and modifiers of hepatocarcinogenesis utilizing the GST-P positive liver cell focus as an endpoint marker. 262 99
Chinese medicinal herbs with Jian Pi Li Qi action were tested for their effects in inhibiting the precancerous lesions, gamma-GT positive hepatocellular foci and the expression of oncogenes (N-ras, Ha-ras) in male SD rats. The rats were given one i.p. dose of initiator
DEN
within 24 hours after 2/3 partial hepatectomy. The livers of sacrificed rats were processed to gamma-GT histochemical staining and measuring of oncogenic expression. The results of these two parameters showed that Chinese medicinal herbs with Jian Pi Li Qi action are effective in inhibiting the precursory lesions of
liver cancer
in rats.
...
PMID:[Inhibitory effects of jian pi li qi Chinese medicinal herbs on diethylnitrosamine (DEN)-induced hepatocarcinogenesis in rats]. 267 88
Transforming growth factor alpha (TGF alpha) is a mitogenic growth factor for hepatocytes that may play a role in the development of
liver cancer
in rodents and humans. Epidermal growth factor receptor (EGFR) is the receptor for TGF alpha; its expression is also altered in mitogenic and carcinogenic processes. Homogeneous basophilic foci (HBF), the precursor lesion to hepatocellular carcinomas in peroxisome proliferator (PP)-treated rats, have labeling indices much greater than surrounding liver (approximately 5- to 20-fold) and other types of foci (approximately 2-fold greater than eosinophilic foci; EF). To test the hypothesis that PP-induced HBF over-express TGF alpha and/or EGFR, male F344 rats were treated with the PP WY-14,643 for 22 weeks (1000 p.p.m. in the diet) with (
DEN
-WY) and without (WY) prior diethylnitrosamine initiation (150 mg/kg body wt i.p.). Serial paraffin sections of liver were stained for TGF alpha or EGFR and with hematoxylin and eosin.
DEN
-WY and WY abrogated the small amount of centrilobular TGF alpha staining observed in livers from control rats. Increased staining for TGF alpha was not observed in HBF induced by WY (0/22) or
DEN
-WY (0/101). Additionally, increased EGFR expression was not observed in HBF induced by WY (0/22) or
DEN
-WY (0/19) or in EF induced by
DEN
-WY (0/30). An unexpectedly large proportion of EF induced by
DEN
-WY (6/38) and
DEN
-control (3/11) were TGF alpha-positive. None of the tumors induced by WY (0/13) or
DEN
-WY (0/11) over-expressed TGF alpha. All 13 WY-induced tumors also lacked increased expression of EGFR. TGF alpha over-expression noted in a significant proportion of EF was associated only with those regimens including
DEN
initiation. In conclusion, TGF alpha or EGFR over-expression is not associated with early appearing, rapidly proliferating HBF or tumors induced by PP.
...
PMID:TGF alpha differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotion. 753 Jun 5
In order to investigate the action of oncogenes in experimental hepatocarcinogenesis, the expression of c-myc, N-ras and H-ras were studied during early and late stages of
DENA
induced hepatocarcinogenesis in rats by using in situ hybridization. The results showed that overexpression of c-myc and N-ras was presented in teh proliferation hepatocytes and alternated hepatocytes foci during the early stage of hepatocarcinogenase, and with the formation and progression of hyperplastic hepatocytic nodules, the overexpresion cells of both were increased and often accompanied each other. Overexpression of H-ras appeared in the middle stage of hepatocarcinogenesis. The data obtained indicate that the abnormal expression of N-ras and c-myc in the hepatocarcinogenesis is not only an earlier molecule event which may relate to the initiation of
HCC
, but also the molecular basis for the morphogenesis of
HCC
, and these two functions took synergically. However, the abnormal expression of H-ras may have a promotive effect on the development of preneoplastic lesions, and also suggests that the malignant transformation of hepatocyte needs the cooperation of multiple oncogenes.
...
PMID:[In situ expression of c-myc, N-ras during diethylnitrosamine induced hepatocarcinogenesis]. 874 81
Diethylnitrosamine
(
DEN
) was administered to rats as a single dose, which is known not to give rise to liver tumours without subsequent promotion. Iron dextran (Fe/Dex) was then administered parenterally to the animals, to induce iron overload. At 3 and 6 months after the final Fe/Dex treatments, livers were examined quantitatively for the numbers of the placental form of glutathione-S-transferase (GST-P) expressing foci, the area occupied by these foci and their size distribution. The results demonstrate that iron not only increased the number of foci after
DEN
initiation in the rat liver, but that the area occupied by these lesions increased significantly between 3 and 6 months after initiation. There is no evidence that iron increased the number of GST-P expressing foci present in rats not exposed to
DEN
. This indicates that iron did not act as an initiator in this rodent model of
liver cancer
. The increase in the area of the liver occupied by the foci in iron and
DEN
treated rats was due to an increase in the size of the foci, as well as to an increase in the number of foci. This is the first demonstration that iron can act as a promoter of
DEN
initiated hepatocytes. It also demonstrates that fibrogenesis is not an absolute requirement for the promotion, by iron, of liver foci in the rat, and that this could also be the case for iron overload in man. Iron may also act as a promoter of already initiated hepatocytes in the development of human
liver cancer
, as it does in the rat.
...
PMID:Iron promotes DEN initiated GST-P foci in rat liver. 906 62
The nonsteroidal antiestrogen tamoxifen increases the incidence of rat
liver cancer
through a variety of mechanisms. To compare the effects of tamoxifen (TAM) and a structurally similar analog toremifene (TOR) on rat liver, we determined the ploidy distribution for hepatocytes isolated from rats treated for 18 months with these antiestrogens or the estrogenic compound mestranol (MS). Female Sprague-Dawley rats were subjected to a 70% partial hepatectomy and administered the solvent, trioctanoin, or diethylnitrosamine (10 mg
DEN
/kg). After a 2-week recovery from the surgery, the rats were administered a basal diet or one containing TAM (250 or 500 ppm), TOR (250, 500, or 750 ppm), or MS (0.2 ppm) for 18 months. Pathologic changes in the liver were examined in the 15-22 rats per treatment group at the 18-month time point. An increased incidence of hepatocellular carcinomas (HCC) was detected in the 500 ppm TAM group, but not with the other treatments that did not include
DEN
. Both TOR and TAM promoted formation of
DEN
-initiated HCCs. At sacrifice, four to five rats per group were perfused and the hepatocytes isolated and cultured. Karyotypic analysis was performed on colcemid-blocked cells after 2 days in culture. The hepatic ploidy distribution was characterized in Giemsa-stained metaphase spreads. These studies indicated that chronic treatment with TAM alone resulted in a shift from tetraploid to diploid, as was also observed for rats treated once with
DEN
. TOR and MS alone did not cause this change in hepatic ploidy at the doses examined. A shift toward an increased content of diploid hepatocytes occurred in all rats treated once with
DEN
followed by TAM, TOR, or MS. These results indicate that tamoxifen administration results in a shift toward growth of diploid hepatocytes, thus contributing to its carcinogenic action in the rat liver.
...
PMID:Effect of chronic administration of mestranol, tamoxifen, and toremifene on hepatic ploidy in rats. 971 Sep 54
Liver cancer
is the fifth most common cancer worldwide and unlike certain other cancers, such as colon cancer, a mutational model has not yet been developed. We have performed gene expression profiling of normal and neoplastic livers in C3H/HeJ mice treated with diethylnitrosamine. Using oligonucleotide microarrays, we compared gene expression in liver tumors to three different states of the normal liver: quiescent adult, regenerating adult, and newborn. Although each comparison revealed hundreds of differentially expressed genes, only 22 genes were found to be deregulated in the tumors in all three comparisons. Three of these genes were examined in human hepatocellular carcinomas and were found to be upregulated. As a second method of analysis, we used Representational Difference Analysis (RDA) to clone mRNA fragments differentially expressed in liver tumors versus regenerating livers. We cloned several novel mRNAs that are differentially regulated in murine liver tumors. Here we report the sequence of a novel cDNA whose expression is upregulated in both murine and human hepatocellular carcinomas. Our results suggest that
DEN
-treated mice provide an excellent model for human hepatocellular carcinomas.
...
PMID:Expression profiling and identification of novel genes in hepatocellular carcinomas. 1142 Jun 82
This study was conducted to examine the effects of dietary grape extracts on preneoplastic foci formation in rat hepatocarcinogenesis, and related hepatic enzymes. Male Sprague-Dawley rats were fed basal diet or grape diet containing 15% concentrated grape extracts (68 bricks). The grape diet groups were divided into whole-period grape diet group (
DEN
-GW; grape diet group fed throughout experimental period) and postinitiation grape diet group (
DEN
-GP; grape diet group fed from post initiation stage) according to the starting time point of the grape diet. Hepatocarcinogenesis was induced by diethylnitrosamine (
DEN
; 200 mg/kg bw) and 2/3 partial hepatectomy (
DEN
-B;
DEN
-treated basal diet group,
DEN
-GW, and
DEN
-GP groups), while the control group treated with saline and sham operation (Control group). The formation of placental glutathione (GSH) S-transferase positive (GST-P+) foci in
DEN
-GW group was moderately but significantly suppressed, however, not in
DEN
- GP group. Thiobarbituric acid reactive substances content of
DEN
-GW group was significantly lower than that of
DEN
-B group. The activity of fatty acid synthase (FAS) in the grape diet groups was decreased about 1/2 of the
DEN
-B group. The content of GSH and GSH peroxidase activity were increased by carcinogen treatment, but not modulated by grape diet. The activities of GSH S-transferase, p-nitrophenol hydroxylase, and catalase were not affected by diet or treatment. Conclusively, the grape diet-induced reduction of FAS activity that was expressed highly in neoplastic tissues, might be one of the contributing mechanisms of
hepatic cancer
prevention.
...
PMID:Grape extracts suppress the formation of preneoplastic foci and activity of fatty acid synthase in rat liver. 1464 90
The present investigation was carried out to evaluate the antioxidant nature of ethanolic extract of Terminalia arjuna bark (EETA) on N-nitrosodiethylamine (
DEN
) induced
liver cancer
in male Wistar albino rats.
Liver cancer
was induced by single intraperitonial injection of
DEN
(200 mg/kg). After 2 weeks of
DEN
administration, Phenobarbital (PB) was given to promote the cancer for up to 14 successive weeks. EETA extract (400 mg/kg) was given post-orally for 28 days to hepatocellular carcinoma-bearing rats. After the experimental period, all the animals were sacrificed and serum, liver and kidney samples were collected for further biochemical analysis. The levels of lipid peroxides (LPO) under basal and also in the presence of inducers (H(2)O(2), ascorbate and FeSO(4)) were estimated in serum, liver and kidney of control and experimental animals. Enzymic antioxidants, such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and non-enzymic antioxidants like Vitamin C (Vit-C) and Vitamin E (Vit-E) levels were determined in all the groups of animals. A significant increase in LPO levels were observed while the levels of enzymic and non-enzymic antioxidants were decreased, when subjected to
DEN
induction. These altered enzyme levels were ameliorated significantly by administration of EETA at the concentration of 400 mg/kg in drug-treated animals. This protective effect of EETA was associated with inhibition of LPO induced by
DEN
and to maintain the antioxidant enzyme levels. Our results show an antioxidant activity of T. arjuna bark against
DEN
-induced
liver cancer
.
...
PMID:Antioxidant activity of Terminalia arjuna bark extract on N-nitrosodiethylamine induced hepatocellular carcinoma in rats. 1632 60
1
2
3
4
5
6
7
8
Next >>